SMAD2 and breast carcinoma: In contrast, the PRP supplementation promotes EMT in luminal B and HER2+ epithelial breast cancer cells with the expression of metastasis markers such as Smad2 and Snail1 due to the TGF-β1 mediated pathway [34].